Coronary Angiography
For a patient with moderate ischemia on SPECT, angina symptoms, and normal ejection fraction, the next step is invasive coronary angiography to define coronary anatomy and guide revascularization decisions.
Rationale for Invasive Strategy
The 2014 ACC/AHA Stable Ischemic Heart Disease guidelines explicitly support coronary angiography for patients with "high-risk" noninvasive stress test findings as a requisite for revascularization 1. Moderate ischemia on SPECT in a symptomatic patient meets this threshold. The guidelines emphasize that angiography is particularly useful to:
- Define coronary anatomy in patients with high-risk noninvasive findings
- Assess suitability for revascularization in patients with unacceptable ischemic symptoms (symptoms not controlled with medication that limit activity or quality of life) 1
The 2023 AHA/ACC Chronic Coronary Disease guidelines reinforce that in patients with known anatomy and ongoing angina despite guideline-directed medical therapy (GDMT), early invasive angiography and revascularization should be considered to improve symptoms 2. While the ISCHEMIA trial showed no mortality benefit from routine early revascularization, it demonstrated that patients randomized to the invasive strategy experienced significantly greater improvement in angina-related health status, particularly those with more frequent baseline angina 2.
Key Clinical Considerations
Symptom Burden Matters
The presence of angina symptoms is critical here. The 2024 ESC guidelines note that while initial conservative medical management is generally preferred, symptom improvement by revascularization should not be neglected if patients remain symptomatic despite antianginal treatment 3. Your patient has angina, making them a candidate for symptom-driven revascularization.
Normal EF Does Not Preclude Benefit
Although the normal ejection fraction on TTE is reassuring from a prognostic standpoint, research demonstrates that only inducible ischemia (not EF) identifies which patients have short-term benefit from revascularization 4. The moderate ischemia on SPECT is the key finding driving the need for anatomic definition.
Moderate Ischemia Threshold
The 2022 CAD-RADS guidelines suggest that moderate stenosis findings warrant consideration of invasive angiography, particularly when patients have persistent symptoms despite adequate medical therapy 5. The decision should integrate stenosis location and severity with clinical characteristics like angina severity.
Practical Algorithm
Confirm optimal medical therapy: Ensure the patient is on appropriate antianginal medications (beta-blockers, calcium channel blockers, long-acting nitrates) and risk-modifying therapies (aspirin, statin, ACE-I/ARB if indicated)
Proceed to coronary angiography if:
- Angina persists despite medical therapy (your patient)
- Patient desires symptom improvement
- No contraindications to revascularization exist
During angiography, assess:
- Extent and severity of coronary disease
- Suitability for PCI vs CABG
- Consider FFR for intermediate lesions (50-90% stenosis) to confirm hemodynamic significance 1
Revascularization decision based on:
Common Pitfalls to Avoid
- Don't delay angiography for additional stress testing: The patient already has documented moderate ischemia and symptoms—further noninvasive testing adds no value
- Don't assume normal EF means low risk: EF predicts mortality, but ischemia burden predicts revascularization benefit 4
- Don't withhold angiography based on ISCHEMIA trial: That trial excluded patients with unacceptable angina on medical therapy and showed clear symptom benefit from revascularization 2, 6
The evidence strongly supports proceeding directly to invasive coronary angiography in this symptomatic patient with objective evidence of moderate ischemia, with the intent to revascularize if suitable anatomy is identified.